In triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, cell proliferation may be fueled by alternative pathways namely PI3K/AKT/mTOR [7]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.